157 related articles for article (PubMed ID: 19213671)
21. Sunitinib-induced macrocytosis in patients with metastatic renal cell carcinoma.
Rini BI; Choueiri TK; Elson P; Khasawneh MK; Cotta C; Unnithan J; Wood L; Mekhail T; Garcia J; Dreicer R; Bukowski RM
Cancer; 2008 Sep; 113(6):1309-14. PubMed ID: 18618496
[TBL] [Abstract][Full Text] [Related]
22. A Rare Case of Sunitinib-Induced Hyperammonemic Encephalopathy and Hypothyroidism in Metastatic Renal Cell Carcinoma.
Pilanc KN; Elbüken F; Ordu Ç; Köksal G; Tekelioğlu MH; Okutur K; Göksel S; Köksal Ü; Akçal T; Tecimer C
Am J Ther; 2016; 23(2):e583-7. PubMed ID: 24901901
[TBL] [Abstract][Full Text] [Related]
23. Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib.
Rini BI; Tamaskar I; Shaheen P; Salas R; Garcia J; Wood L; Reddy S; Dreicer R; Bukowski RM
J Natl Cancer Inst; 2007 Jan; 99(1):81-3. PubMed ID: 17202116
[TBL] [Abstract][Full Text] [Related]
24. Successful sunitinib treatment of metastatic renal cell carcinoma in a patient with end stage renal disease on hemodialysis.
Park CY
Anticancer Drugs; 2009 Oct; 20(9):848-9. PubMed ID: 19644356
[TBL] [Abstract][Full Text] [Related]
25. Sunitinib-induced acute hemolysis without hypertension: a case report.
Jain R; Mathew P; Wood CG; Tannir NM
Clin Genitourin Cancer; 2008 Sep; 6(2):122-3. PubMed ID: 18824436
[TBL] [Abstract][Full Text] [Related]
26. Pyoderma gangrenosum with the use of sunitinib.
Nadauld LD; Miller MB; Srinivas S
J Clin Oncol; 2011 Apr; 29(10):e266-7. PubMed ID: 21220606
[No Abstract] [Full Text] [Related]
27. Spontaneous bilateral pneumothorax in metastatic renal cell carcinoma on sunitinib therapy.
Katta A; Fesler MJ; Tan A; Vuong G; Richart JM
Cancer Chemother Pharmacol; 2010 Jul; 66(2):409-12. PubMed ID: 20204363
[TBL] [Abstract][Full Text] [Related]
28. Unusual progression of renal cell carcinoma with carcinomatosis peritoneii and Krukenberg tumour and alopecia with sunitinib therapy in young female.
Pandey M; Ramasamy M; Shukla M
World J Surg Oncol; 2018 Feb; 16(1):23. PubMed ID: 29409504
[TBL] [Abstract][Full Text] [Related]
29. Cardiac tamponade in a patient treated by sunitinib for metastatic renal cell carcinoma.
Yıldız I; Varol U; Şen F; Kılıç L
Anadolu Kardiyol Derg; 2014 Nov; 14(7):654-6. PubMed ID: 25163084
[No Abstract] [Full Text] [Related]
30. Sunitinib efficacy against advanced renal cell carcinoma.
Motzer RJ; Michaelson MD; Rosenberg J; Bukowski RM; Curti BD; George DJ; Hudes GR; Redman BG; Margolin KA; Wilding G
J Urol; 2007 Nov; 178(5):1883-7. PubMed ID: 17868732
[TBL] [Abstract][Full Text] [Related]
31. Tumour lysis syndrome in a patient with renal-cell carcinoma treated with sunitinib malate.
Nicholaou T; Wong R; Davis ID
Lancet; 2007 Jun; 369(9577):1923-4. PubMed ID: 17560435
[No Abstract] [Full Text] [Related]
32. Reversible myocardial dysfunction in a young woman with metastatic renal cell carcinoma treated with sunitinib.
Szmit S; Nurzyński P; Szaluś N; Opolski G; Szczylik C
Acta Oncol; 2009; 48(6):921-5. PubMed ID: 19191048
[No Abstract] [Full Text] [Related]
33. Food and Drug Administration drug approval summary: Sunitinib malate for the treatment of gastrointestinal stromal tumor and advanced renal cell carcinoma.
Rock EP; Goodman V; Jiang JX; Mahjoob K; Verbois SL; Morse D; Dagher R; Justice R; Pazdur R
Oncologist; 2007 Jan; 12(1):107-13. PubMed ID: 17227905
[TBL] [Abstract][Full Text] [Related]
34. [Treatment with sunitinib and hypothyroidism--a case report and overview of literature].
Kreze A; Stáhalová V; Zadrazilová A; Koskuba J; Kosák M
Klin Onkol; 2009; 22(4):176-8. PubMed ID: 19731880
[TBL] [Abstract][Full Text] [Related]
35. Genital and inguinal cutaneous toxicity in male and female patients treated with sunitinib.
Iacovelli R; Mancini ML; Risi E; Palazzo A; Cortesi E
Int J Dermatol; 2012 Feb; 51(2):221-2. PubMed ID: 22250635
[TBL] [Abstract][Full Text] [Related]
36. Life-threatening acute acalculous cholecystitis in a patient with renal cell carcinoma treated by sunitinib: a case report.
Nakano K; Suzuki K; Morita T
J Med Case Rep; 2012 Feb; 6():69. PubMed ID: 22348690
[TBL] [Abstract][Full Text] [Related]
37. Role of sunitinib and SU12662 on dermatological toxicities in metastatic renal cell carcinoma patients: in vitro, in vivo, and outcomes investigation.
Teo YL; Chong XJ; Chue XP; Chau NM; Tan MH; Kanesvaran R; Wee HL; Ho HK; Chan A
Cancer Chemother Pharmacol; 2014 Feb; 73(2):381-8. PubMed ID: 24306119
[TBL] [Abstract][Full Text] [Related]
38. Aortic dissection in a patient treated by sunitinib for metastatic renal cell carcinoma.
Edeline J; Laguerre B; Rolland Y; Patard JJ
Ann Oncol; 2010 Jan; 21(1):186-7. PubMed ID: 19875754
[No Abstract] [Full Text] [Related]
39. [A case of interstitial lung disease due to sunitinib].
Sekiguchi Z; Takizawa A; Takeshima T; Tsuchiya F; Iwasaki A; Matsuyama S; Hirooka N
Hinyokika Kiyo; 2012 Sep; 58(9):481-5. PubMed ID: 23070386
[TBL] [Abstract][Full Text] [Related]
40. Olecranon bursitis in patients treated with sunitinib for renal cell carcinoma.
Gregory T; Mir O; Medioni J; Augereau B; Oudard S
Med Oncol; 2010 Jun; 27(2):446-8. PubMed ID: 19444655
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]